Cipta Sarana Medika Tbk. vs Penta Valent Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 24.02M 24h volume), while Penta Valent Tbk. trades at Rp310 (market cap 547.34B, 520.2K 24h volume). The key difference: Penta Valent Tbk. is far larger — about 3.4× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (24.02M versus 520.2K). Which is the better fit depends on your goals.
| DKHH | PEVE | |
|---|---|---|
Market Cap | 160.67B | 547.34B |
Volume | 24.02M | 520.2K |
Lot | 240.19K | 5.2K |
Turnover | 1.56B | 161.08M |
Average Price | 65 | 309.65 |
Value | 1.56B | 161.08M |
Indicative Equilibrium Price | 64 | — |
Indicative Equilibrium Volume | 1.67K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Penta Valent Tbk (the Company) was established in 1968 in Jakarta, Indonesia under the name of CV Penta Valent, hereinafter, based on Notarial Deed No. 48 of Bebasa Daeng Lalo, S.H., dated August 16, 1972. The Company started its commercial operations in 1968. PT Tancorp Global Sentosa, a company incorporated in Indonesia, is the ultimate parent entity of the Company.
Read more on PEVE →